Prosecution Insights
Last updated: November 04, 2026

BENETHERA (BEIJING) BIOTECHNOLOGY CO., LTD.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

BENETHERA (BEIJING) BIOTECHNOLOGY CO., LTD. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, NGUYEN, QUANG. The prosecution is restricted to 1 distinct art unit, indicating a narrow technical focus for the company's active biotechnology filings. This concentration within a single art unit can lead to a more specialized examination of the pharmaceutical claims.

The busiest examiner, NGUYEN, QUANG, manages 1 pending office action. Given that there is only 1 distinct examiner and 1 pending action, the company's current prosecution efforts are entirely concentrated. This provides a singular point of interaction for the company's pharmaceutical intellectual property at the patent office. The busiest examiner pending figure of 1 confirms that the company's current prosecution strategy is entirely centered on the feedback from this specific individual.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUYEN, QUANG 1 37.8% +52.7%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17998855 T CELL, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF NGUYEN, QUANG —

Top Art Units

Art UnitApps
1631 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17998855 T CELL, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF NGUYEN, QUANG 1631 §103 Non-Final OA — Pending Nov 15, 2022

Managing BENETHERA (BEIJING) BIOTECHNOLOGY CO., LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does BENETHERA (BEIJING) BIOTECHNOLOGY CO., LTD. have?

BENETHERA (BEIJING) BIOTECHNOLOGY CO., LTD. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most BENETHERA (BEIJING) BIOTECHNOLOGY CO., LTD. applications?

Quang Nguyen has the most, with 1 of BENETHERA (BEIJING) BIOTECHNOLOGY CO., LTD.'s pending office actions.

What technology area are BENETHERA (BEIJING) BIOTECHNOLOGY CO., LTD.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month